Iron Dysregulation in Cardiovascular Diseases

被引:1
|
作者
Wang, Hui [1 ]
Huang, Zhongmin [1 ]
Du, Chenyan [1 ]
Dong, Mingqing [1 ]
Fragasso, Gabriele [1 ]
机构
[1] Chengdu Fifth Peoples Hosp, Geriatr Dis Inst Chengdu, Ctr Med Res & Translat, Chengdu 611137, Sichuan, Peoples R China
关键词
iron metabolism; homeostasis; cardiovascular disease; dysregulation; CHRONIC HEART-FAILURE; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; HEREDITARY HEMOCHROMATOSIS; ENDOTHELIAL DYSFUNCTION; TRANSFERRIN RECEPTOR; EXERCISE CAPACITY; OXIDATIVE STRESS; OVERLOAD; HEPCIDIN;
D O I
10.31083/j.rcm2501016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Lead Exposure and Cardiovascular Dysregulation in Children
    MacKenzie, James A.
    Gump, Brooks B.
    Roosa, Kristen
    Bendinskas, Kestas
    Dumas, Amy
    Morgan, Robert
    Parsons, Patrick
    FASEB JOURNAL, 2009, 23
  • [32] Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases
    Rassu, Giovanna
    Salis, Andrea
    Porcu, Elena Piera
    Giunchedi, Paolo
    Roldo, Marta
    Gavini, Elisabetta
    CARBOHYDRATE POLYMERS, 2016, 136 : 1338 - 1347
  • [33] tRNA Dysregulation in Neurodevelopmental and Neurodegenerative Diseases
    Burgess, Robert W.
    Storkebaum, Erik
    ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2023, 39 : 223 - 252
  • [34] Dysregulation of axonal transport and motorneuron diseases
    Sau, Daniela
    Rusmini, Paola
    Crippa, Valeria
    Onesto, Elise
    Bolzoni, Elena
    Ratti, Antonia
    Poletti, Angelo
    BIOLOGY OF THE CELL, 2011, 103 (02) : 87 - 107
  • [35] Dysregulation of immune homeostasis in autoimmune diseases
    Kuchroo, Vijay K.
    Ohashi, Pamela S.
    Sartor, R. Balfour
    Vinuesa, Carola G.
    NATURE MEDICINE, 2012, 18 (01) : 42 - 47
  • [36] Autophagy and microRNA dysregulation in liver diseases
    Kyu Min Kim
    Sang Geon Kim
    Archives of Pharmacal Research, 2014, 37 : 1097 - 1116
  • [37] Dysregulation of Carnosine Metabolism in Progression of Diseases
    Bozko, Przemyslaw
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (11) : 1713 - 1713
  • [38] Autonomic dysregulation at baseline in neurodegenerative diseases
    Guo, Christine
    Sturm, V. E.
    Zhou, J.
    Trujillo, A.
    Gennatas, E.
    Miller, B. L.
    Seeley, W. W.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 155 - 155
  • [39] Metabolic dysregulation of lymphocytes in autoimmune diseases
    Wang, Shuyi
    Yang, Niansheng
    Zhang, Hui
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2024, 35 (07): : 624 - 637
  • [40] Dysregulation of histone deacetylases in ocular diseases
    Jun, Jae Hyun
    Kim, Jun-Sik
    Palomera, Leon F.
    Jo, Dong-Gyu
    ARCHIVES OF PHARMACAL RESEARCH, 2024, 47 (01) : 20 - 39